Mutations can significantly alter PPI networks by changing the structure and function of proteins, leading to aberrant interactions. These disruptions can activate oncogenic pathways or inactivate tumor suppressor functions. By mapping these altered networks, researchers can understand the molecular mechanisms underlying different types of cancer and develop more effective treatment strategies.
